T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
RPM International
RPM
$14.7B
| $511M | 0.11% |
10,637,742
+1,169,685
| +12% | +$56.6M |
|
227
Marriott International
MAR
$92.5B
| $510M | 0.11% |
6,344,045
-44,552
| -0.7% | -$3.55M |
|
228
L3Harris
LHX
$54.1B
| $506M | 0.1% |
6,427,565
-4,505
| -0.1% | -$328K |
|
229
Murphy Oil
MUR
$5.06B
| $506M | 0.1% |
10,863,350
+685,740
| +7% | +$33.1M |
|
230
Coca-Cola
KO
$373B
| $503M | 0.1% |
12,416,357
-837,230
| -6% | -$35M |
|
231
Loews
L
$23.1B
| $502M | 0.1% |
12,284,283
+2,342,907
| +24% | +$94.9M |
|
232
Progressive
PGR
$121B
| $500M | 0.1% |
18,375,719
-4,171,377
| -19% | -$111M |
|
233
SS&C Technologies
SSNC
$18.8B
| $499M | 0.1% |
16,019,556
+308,120
| +2% | +$9.15M |
|
|
MWV
234
DELISTED
MEADWESTVACO CORP
MWV
| $497M | 0.1% |
9,972,986
-359,040
| -3% | -$17.9M |
|
235
American Electric Power
AEP
$67.9B
| $493M | 0.1% |
8,761,070
-2,414,203
| -22% | -$143M |
|
236
Trip.com Group
TCOM
$28.7B
| $492M | 0.1% |
16,784,460
-21,962,332
| -57% | -$530M |
|
|
GRUB
237
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $491M | 0.1% |
5,412,434
-489,510
| -8% | -$39.4M |
|
238
DaVita
DVA
$11.6B
| $489M | 0.1% |
6,015,820
+308,403
| +5% | +$23.7M |
|
239
Micron Technology
MU
$1.03T
| $489M | 0.1% |
18,014,609
+4,215,154
| +31% | +$126M |
|
240
Bruker
BRKR
$9.03B
| $486M | 0.1% |
26,314,240
+209,430
| +0.8% | +$3.97M |
|
|
XEC
241
DELISTED
CIMAREX ENERGY CO
XEC
| $485M | 0.1% |
4,212,300
+161,626
| +4% | +$17.3M |
|
242
Zurn Elkay Water Solutions
ZWS
$8.46B
| $483M | 0.1% |
37,555,012
+448,063
| +1% | +$5.73M |
|
243
Global Payments
GPN
$23.4B
| $482M | 0.1% |
10,522,152
+141,908
| +1% | +$6.33M |
|
244
Palo Alto Networks
PANW
$315B
| $480M | 0.1% |
19,729,884
+1,909,104
| +11% | +$42.7M |
|
|
MBLY
245
DELISTED
Mobileye N.V.
MBLY
| $479M | 0.1% |
11,407,299
+4,676,016
| +69% | +$182M |
|
|
FEIC
246
DELISTED
FEI COMPANY
FEIC
| $476M | 0.1% |
6,236,671
+867,168
| +16% | +$69.4M |
|
247
Corning
GLW
$144B
| $470M | 0.1% |
20,707,060
-336,880
| -2% | -$8.01M |
|
248
ASML
ASML
$695B
| $470M | 0.1% |
4,647,571
-1,847,132
| -28% | -$194M |
|
249
Stanley Black & Decker
SWK
$15.5B
| $468M | 0.1% |
4,909,863
-55,182
| -1% | -$5.28M |
|
|
HAR
250
DELISTED
Harman International Industries
HAR
| $464M | 0.1% |
3,469,126
-329,518
| -9% | -$41M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.